Pharmaceutical Executive September 9, 2024
In this part of their Pharmaceutical Executive video interview, UpScriptHealth’s Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, and the potential health risks associated with them.
How widespread is the issue of counterfeit weight loss drugs, particularly fake Ozempic, and what are the potential health risks associated with these products?
Peter Ax: When we’re talking about weight loss growth, we’re really talking about the GLP ones, which are so popular right now. And as early estimates were that the market is going to be about a $50 billion market at scale. More recent estimates are saying it’ll be as much as $100 billion plus market. And what we’ve assumed...
Today's Sponsors
Today's Sponsor